Biotech Values

[biomaven0]

I'd like to know if the announced median OS in the control arm reflects all ITT patients, or just the non-censored patients on their KM curve. In other words, is that < 6 months figure mature or not.

If it's ITT, then any delay is indeed good.

From an investment perspective, I note they have an ATM sales program. While that is in effect I would absolutely avoid the stock - historically stocks with these programs don't do well.

Peter